It's NOT the prices, stupid?
https://www.kff.org/report-section/health-care-costs-a-primer-2012-report/

It's NOT the prices, stupid?

A famous paper by Anderson et al. (2003) attempted to explain why health care in the U.S. is so expensive. The answer: "It's the prices, stupid." However, is that really the case?

A fascinating blog post on Random Critical Analysis disputes this piece of conventional wisdom. In the U.S., prices certainly have risen. However, they have largely risen in parallel with average incomes. Since healthcare is very labor dependent, it should not be a surprise that changes in health care prices are largely proportional to changes in disposable income (or GDP). What is driving rising health care spending is increased utilization of health care per person.

No alt text provided for this image


More health care per person is not only about the number of hospitalizations or number of office visits. Rather, the intensity of services provided during a hospitalization or office visit is much higher, likely due to improvements in health technology. For instance, we see that cost per inpatient admission rose faster than income, which likely suggests (but does not prove) that there was an increase in intensity of services provided.

No alt text provided for this image

The U.S. also has worse health outcomes than many developed countries. Is it a problematic health system? In fact, lifestyle factors such as obesity, smoking, traffic accidents, homicides and drug overdoses explain much of this difference.

No alt text provided for this image

As the Random Critical Analysis piece states, conventional wisdom on why US health care costs are so high may not always turn out to be correct. 

Originally posted at Healthcare Economist.

要查看或添加评论,请登录

Jason Shafrin的更多文章

  • Calculating Social Vulnerability Index by ZIP Code

    Calculating Social Vulnerability Index by ZIP Code

    A paper by Ng, Zhang and Kowal (2025) use the American Community Survey (ACS) data from 2016–2022 were used to…

    1 条评论
  • Value-Based Pricing for Drugs With Uncertain Clinical Benefits

    Value-Based Pricing for Drugs With Uncertain Clinical Benefits

    This is the title of a recent paper by Jiao et al. (2025).

    1 条评论
  • About face for RFK Jr. on MMR vaccine?

    About face for RFK Jr. on MMR vaccine?

    Last month, I noted that the decrease in vaccination rates has likely resulted in increased rates of measles in Texas…

    1 条评论
  • The value of knowing is not always positive

    The value of knowing is not always positive

    An interesting article by Ciancio et al. (2025) which examines the impact of learning one has HIV when no treatment is…

    1 条评论
  • More evidence that there are diminishing marginal returns to quality of life gains

    More evidence that there are diminishing marginal returns to quality of life gains

    Quality-adjusted life years (QALYs) are commonly used to evaluate the impact of new medical technologies on patient…

  • Quotation of the Day

    Quotation of the Day

    There is nothing so useless as doing efficiently that which should not be done at all. Peter Drucker

    1 条评论
  • What is Project IDEATE?

    What is Project IDEATE?

    How best can you design an outcomes based agreement (OBA)? What are the key factors to consider? Project IDEATE is a…

  • Can the NIH replace all private sector clinical R&D?

    Can the NIH replace all private sector clinical R&D?

    A paper by Proudman et al. (2024) finds that doing so would be extremely expensive.

    4 条评论
  • Vaccine choice = more measles infection

    Vaccine choice = more measles infection

    Texas is moving to allow for more freedom of choice with respect to receipt of vaccines. The Economist reports: Texas…

    3 条评论
  • Healthcare Economist named a top 100 Economics blog

    Healthcare Economist named a top 100 Economics blog

    In Feedspot's 2025 ranking of economics blogs, Healthcare Economist was once again ranked in the top 100 (#44). I was…

    16 条评论

社区洞察